Lariago 250mg Tablet
By Lariago
Rx
10 Tablet in a Strip

Composition
Chloroquine(250mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
August, 2027

liver
For individuals with liver disease, it is important to use Lariago 250mg Tablet with caution. It may be necessary to adjust the dosage of the medication, so consulting your doctor is crucial before starting treatment. Additionally, regular monitoring of liver function tests may be recommended while you are using this medicine. This is to ensure your liver is functioning properly and to address any potential issues promptly.

kidney
Lariago 250mg Tablet needs caution in kidney disease patients. Dose adjustment may be necessary. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Lariago 250mg Tablet.

driving
Caution - Driving Lariago 250mg Tablet may cause side effects such as blurred eyesight or difficulty focusing, which can affect your ability to drive safely.

pregnancy
Lariago 250mg Tablet may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Consult with your doctor for a thorough evaluation of benefits and risks before using this medication.

breastfeeding
Lariago 250mg Tablet is considered safe to use during breastfeeding. Studies show that it does not pass into breastmilk in harmful amounts, posing no risk to the baby.
Habit Forming | No |
Chemical Class | 4-Aminoquinoline Derivative |
Therapeutic Class | OPHTHAL |
Action Class | Antimalarial- Aminoquinolines |
₹13.97
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025